Clinical Trial

Subthalamic Nucleus Versus Globus Pallidal Internus Deep Brain Stimulation for Parkinson Disease

Study acronym: Superior PD
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this prospective, multicenter, double-blind, randomized, crossover clinical trial is to evaluate whether Subthalamic Nucleus-Deep Brain Stimulation (STN-DBS) is more effective than Globus Pallidus Internus-Deep Brain Stimulation (GPi-DBS) in improving motor symptoms of patients with Parkinson's disease at 90 days post-treatment.
Trial Details
NCT Number NCT07250685
Lead Sponsor Zhang Jianguo
Conditions PD - Parkinson's Disease
Enrollment 86 participants
Start Date 2025-11-24
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-11-26